Cargando…

Does Reinfusion of Stem Cell Products on Multiple Days Affect Engraftment?

OBJECTIVE: High-doses of melphalan treatment with autologous stem cell transplantation in multiple myeloma (MM) remains a major treatment modality in suitable patients. A minimal dose of 2x10(6)/kg CD34+ cells is preferred to achieve engraftment. Some patients need multiple leukapheresis procedures...

Descripción completa

Detalles Bibliográficos
Autores principales:	Solmaz Medeni, Şerife, Türkyılmaz, Doğuş, Acar, Celal, Sevindik, Ömür Gökmen, Yüksel, Faize, Pişkin, Özden, Özcan, Mehmet Ali, Demirkan, Fatih, Ündar, Bülent, Alacacıoğlu, İnci, Özsan, Güner Hayri
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Galenos Publishing 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6256826/ https://www.ncbi.nlm.nih.gov/pubmed/29923493 http://dx.doi.org/10.4274/tjh.2018.0071

Ejemplares similares

Renal and Neurological Response with Eculizumab in a Patient with Transplant Associated Thrombotic Microangiopathy after Allogeneic Hematopoietic Progenitor Cell Transplantation
por: Sevindik, Ömür Gökmen, et al.
Publicado: (2015)

Is the platelet-to-lymphocyte ratio a new prognostic marker in multiple myeloma?
por: Solmaz, Serife, et al.
Publicado: (2018)

Prognostic Factors in Elderly Patients with Diffuse Large B-Cell Lymphoma and Their Treatment Results
por: Adıyaman, Süleyman Cem, et al.
Publicado: (2019)

Mast cell leukemia associated with undefined morphology and chronic basophilic leukemia
por: Cehreli, Cavit, et al.
Publicado: (2014)

The Effect of FcγRIIIA Gene Polymorphism on the Treatment of Diffuse Large B-cell Non-Hodgkin Lymphoma: A Multicenter Prospective Observational Study
por: Büyükkurt, Nurhilal, et al.
Publicado: (2015)

Assessment of Bone Marrow Biopsy and Cytogenetic Findings in Patients with Multiple Myeloma
por: Şeyhanlı, Ahmet, et al.
Publicado: (2022)

Predictive value of stathmin-1 and osteopontin expression for taxan resistance in metastatic castrate-resistant prostate cancer
por: Aksoy, Asude, et al.
Publicado: (2017)

P872: EFFICACY OF DARATUMUMAB PLUS BORTEZOMIB, CYCLOPHOSPHAMIDE AND DEXAMETHASONE IN PATIENTS WITH MULTIPLE MYELOMA PRESENTING WITH EXTRAMEDULLARY DISEASE: A EUROPEAN MYELOMA NETWORK STUDY (EMN19)
por: Beksac, Meral, et al.
Publicado: (2023)

Persistent Polyclonal B-Cell Lymphocytosis with Binucleated Lymphocytes
por: Balık Aydın, Berrin, et al.
Publicado: (2021)

PB2007: FACTORS ASSOCIATED WITH EARLY RELAPSE IN MYELOMA PATIENTS AFTER AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Karatas, A., et al.
Publicado: (2022)

First-line Usage of Daratumumab, Lenalidomide, Dexamethasone (DRd) Combination in a Case of Castleman Disease Variant of Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes Syndrome (CD-POEMS)
por: Sevindik, Omur Gokmen, et al.
Publicado: (2022)

Postoperative Autologous Reinfusion in Total Knee Replacement
por: Crescibene, A., et al.
Publicado: (2015)

PB2181: DOES SARCOPENIA INFLUENCE THE SUCCESS OF HEMATOPOIETIC STEM CELL TRANSPLANTATION?
por: Erdogan Yucel, E., et al.
Publicado: (2022)

Prognostic Significance of Serum Galectin-3 Levels in Patients with Hepatocellular Cancer and Chronic Viral Hepatitis
por: Ulu, Mehmet, et al.
Publicado: (2015)

Survival outcomes of hypomethylating agents maintenance therapy in new diagnosed AML patients: Real experience data
por: Karakus, Volkan, et al.
Publicado: (2022)

Newly onset cytopenias not always indicate a relapsing AML after allogeneic HSCT, a case of non-destructive post transplant lymphoproliferative disorder
por: Yiğit Kaya, Süreyya, et al.
Publicado: (2023)

Oral Bile Reinfusion in Chronic Percutaneous Transhepatic Cholangiodrainage
por: Kahl, Alyssa, et al.
Publicado: (2020)

PB1889: A CASE OF REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA INDUCED IMMUNE THROMBOCYTOPENIC PURPURA SUCCESSFULLY TREATED WITH VENETOCLAX
por: Yavuz, B., et al.
Publicado: (2022)

To rechallenge or not to rechallenge, that is the question? An unsuccessful attempt of hypomethylating agent plus venetoclax in an elderly FLT3-positive relapsed acute myeloid leukemia patient after a yearlong period of remission
por: Sevindik, Omur Gokmen, et al.
Publicado: (2022)

Should Core Needle Lymph Node Biopsy be a Relevant Alternative to Surgical Excisional Biopsy in Diagnostic Work Up of Lymphomas?
por: Gül Mutlu, Yaşa, et al.
Publicado: (2023)

The effects on coagulation of the reinfusion of unprocessed residual blood from the cardiopulmonary bypass
por: Iyer, Yolande-Leigh, et al.
Publicado: (2016)

Stoma-Output Reinfusion Device for Ileostomy Patients: A Feasibility Study
por: Liu, Chen, et al.
Publicado: (2021)

An adult case of atypical hemolytic uremic syndrome presented with posterior reversible encephalopathy syndrome: Successful response to late-onset eculizumab treatment
por: Medeni, Serife Solmaz, et al.
Publicado: (2018)

Relapsed refractory multiple myeloma with CNS involvement successfully treated with Elranatamab: first reported case
por: Mutlu, Yasa Gul, et al.
Publicado: (2023)

Acute Lymphoblastic Leukemia in Routine Practice: A Turkish Multicenter Study
por: Çiftçiler, Rafiye, et al.
Publicado: (2019)

Eltrombopag for the Treatment of Immune Thrombocytopenia: The Aegean Region of Turkey Experience
por: Özdemirkıran, Füsun, et al.
Publicado: (2015)

Essential Role of P-Selectin in the Initiation of the Inflammatory Response Induced by Hemorrhage and Reinfusion
por: Scalia, Rosario, et al.
Publicado: (1999)

Closed suction drains, reinfusion drains or no drains in primary total knee replacement?
por: Al-Zahid, S, et al.
Publicado: (2012)

Chyme Reinfusion in Intestinal Failure Related to Temporary Double Enterostomies and Enteroatmospheric Fistulas
por: Picot, Denis, et al.
Publicado: (2020)

In vitro investigation of a new thrombus aspiration and autologous blood reinfusion system
por: Li, Weixiao, et al.
Publicado: (2019)

The Scope of Kidney Affection in Monoclonal Gammopathies at All Levels of Clinical Significance
por: Mehtat Ünlü, Şadiye, et al.
Publicado: (2017)

Are reinfusion drains safe to use with periarticular liposomal bupivacaine? An analysis of systemic bupivacaine toxicity
por: Angerame, Marc R., et al.
Publicado: (2017)

Weaning from concentrated ascites reinfusion therapy for refractory ascites by SGLT2 inhibitor
por: Miyamoto, Yasunori, et al.
Publicado: (2021)

A single center cohort of 40 severe COVID-19 patients who were treated with convalescent plasma
por: GEMİCİ, Aliihsan, et al.
Publicado: (2020)

Gilteritinib (XOSPATA®) in Turkey: Early Access Program Results
por: Dogu, Mehmet Hilmi, et al.
Publicado: (2023)

PB1897: GILTERITINIB IN TURKEY: EARLY ACCESS PROGRAM RESULTS
por: Dogu, Mehmet Hilmi, et al.
Publicado: (2023)

Adaptive phenotypic modulations lead to therapy resistance in chronic myeloid leukemia cells
por: Baykal-Köse, Seda, et al.
Publicado: (2020)

Reinfusion of ascites during hemodialysis as a treatment of massive refractory ascites and acute renal failure
por: Hsu, Ta-Wei, et al.
Publicado: (2011)

Cardiorespiratory effects of venous lipid micro embolization in an experimental model of mediastinal shed blood reinfusion
por: Eyjolfsson, Atli, et al.
Publicado: (2009)

Self-administered succus entericus reinfusion before ileostomy closure improves short-term outcomes
por: Liu, Zhen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hds2v4md4uf2oqb9nbgpoqu86j